126 related articles for article (PubMed ID: 1034920)
21. The action of compound WA-335 on the central nervous system.
Maj J; Baran L; Sowińska H; Gancarczyk L
Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
[TBL] [Abstract][Full Text] [Related]
22. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
Malec D; Langwiński R
Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
[TBL] [Abstract][Full Text] [Related]
23. On the pharmacology of the ergot alkaloid elymoclavine.
Petkov V; Georgiev V; Roussinov K; Grigorov I; Slokoska L; Angelova M; Lazarova M; Getova D; Todorov S; Radomirov R
Biomed Biochim Acta; 1984; 43(11):1305-16. PubMed ID: 6442580
[TBL] [Abstract][Full Text] [Related]
24. Neuroleptic-like, anticonvulsant and antinociceptive effects of aporphine alkaloids: bulbocapnine, corytuberine, boldine and glaucine.
Zetler G
Arch Int Pharmacodyn Ther; 1988; 296():255-81. PubMed ID: 2907279
[TBL] [Abstract][Full Text] [Related]
25. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
Przegalinski E; Baran L; Kedrek G
Pol J Pharmacol Pharm; 1980; 32(4):485-93. PubMed ID: 6265886
[TBL] [Abstract][Full Text] [Related]
26. Psychopharmacological profile of dexamisole.
Przegaliński E; Bigajska K; Siwanowicz J
Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological properties of new derivatives of 1-diphenylacetamide-2-butanol.
Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Zejc A; Gajewczyk L
Pol J Pharmacol Pharm; 1989; 41(5):475-81. PubMed ID: 2577062
[TBL] [Abstract][Full Text] [Related]
28. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
Wachtel H; Kehr W; Sauer G
Life Sci; 1983 Dec; 33(26):2583-97. PubMed ID: 6607392
[TBL] [Abstract][Full Text] [Related]
29. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
30. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
[TBL] [Abstract][Full Text] [Related]
31. Effect of angiotensin on the central action of dopamine.
Braszko J; Wiśniewski K
Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
[TBL] [Abstract][Full Text] [Related]
32. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
33. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
[TBL] [Abstract][Full Text] [Related]
34. Is dopamine antagonism a requisite of neuroleptic activity?
Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
[TBL] [Abstract][Full Text] [Related]
35. The effect of lithium chloride on the activity of some psychotropic drugs.
Wielosz M
Pol J Pharmacol Pharm; 1976; 28(2):189-98. PubMed ID: 945563
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
Ahtee L
Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
Subarnas A; Tadano T; Oshima Y; Kisara K; Ohizumi Y
J Pharm Pharmacol; 1993 Jun; 45(6):545-50. PubMed ID: 8103103
[TBL] [Abstract][Full Text] [Related]
38. Preliminary evaluation of manassantin A, a potential neuroleptic agent from Saururus cernuus.
Rao KV; Puri VN; Diwan PK; Alvarez FM
Pharmacol Res Commun; 1987 Sep; 19(9):629-38. PubMed ID: 2893391
[TBL] [Abstract][Full Text] [Related]
39. [Effect of beta-phenylethylamine derivatives on the central nervous system. III. Motor activity changes in mice due to the intracerebral administration of metaraminol].
Shoji T; Sakurada S; Kisara K
Nihon Yakurigaku Zasshi; 1975 Jan; 71(1):11-8. PubMed ID: 1171809
[TBL] [Abstract][Full Text] [Related]
40. The neuropharmacological actions of amoxapine.
Greenblatt EN; Lippa AS; Osterberg AC
Arch Int Pharmacodyn Ther; 1978 May; 233(1):107-35. PubMed ID: 28699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
